Greater China
China cancer screening specialist raises $99m
China Merchants Capital has led a $99.5 million funding round for Berry Oncology Corporation, an early cancer screening spin-out from China-based genetic testing specialist Berry Genomics.
Primavera pursues China online education take-private
Primavera Capital Group has submitted a $33.3 million take-private bid for Liulishuo, a China-based operator of an English language learning app. The company's stock has struggled following a recent crackdown on online education platforms in China.
GLP, Sequoia commit $800m to China's Harvest Capital
Harvest Capital, a China-based private equity firm that focuses on the consumer sector, has received a strategic investment of nearly $800 million from GLP – a regional logistics platform and investment manager- and Sequoia Capital China.
China AI drug developer BioMap raises $100m
GGV Capital has led a $100 million Series A round for BioMap, a China-based biological computing platform. It marks the first time the company has sought external funding.
Coller spins out credit fund interests from Ping An subsidiary
A Coller Capital-led consortium has acquired interests in four global credit funds – worth a combined $680 million – from China Ping An Insurance’s overseas investment platform.
China autonomous driving start-up Inceptio raises $270m
Inceptio, a Chinese autonomous driving technology provider focusing on line-haul trucking, has raised a $270 million Series B round led by JD Logistics, Meituan, and PAG.
Profile: E15 VC's Philip Liang
From social networking for dogs to surgical robotics, Philip Liang’s career as an entrepreneur and investor has been rich and varied. He welcomes the barrage of ideas filling his inbox at Hong Kong-based E15 VC
China's Vitalbridge reaches $200m first close on Fund II
Vitalbridge Capital, a China-based venture capital firm that spun out from Trustbridge Partners, has achieved a first close of $200 million on its second US dollar-denominated fund.
CMC invests $93m in China liquor brand
Forty-Nine Union, a Chinese liquor brand, has raised a Series B round of RMB600 million ($93 million) from CMC Capital Group. There were no other participants in the round.
PAG raises $525m for second China growth fund
PAG has closed its second growth fund, which makes middle-market investments – predominantly in China – that fall below the minimum check size for its pan-Asian vehicle at $525 million.
Navis raises $900m for Fund VIII, closes Fund VI continuation
Navis Capital Partners has closed its eighth regional fund at $900 million, while also securing $450 million for a continuation vehicle that features five companies from its sixth fund.
Sequoia China leads $100m Series B for Bota Biosciences
Sequoia Capital China had led a $100 million Series B round for Bota Biosciences, a China-based biotech company that has developed a next-generation platform for manufacturing high-performing industrial compounds.
Airwallex founders launch VC fund
The founders of Hong Kong-headquartered financial technology provider Airwallex, which has received $500 million in VC funding, have launched their own venture capital fund.
GIC invests $240m in Arctic Green Energy
Singapore sovereign wealth fund GIC has committed $240 million to Arctic Green Energy (AGE), an Iceland-based geothermal energy developer that has already received substantial Chinese backing.
China automotive chip maker Semidrive raises $154m
Semidrive Technology, a specialist semiconductor manufacturer for the automotive industry, has raised RMB1 billion ($154 million) in Series B funding led by Pro Capital and V Fund.
China's Genesis targets $1.2b for Fund III
Genesis Capital, a China growth-stage technology investor established by Richard Peng, who previously led the investment program at Tencent Holdings, is seeking $1.2 billion for its third US dollar-denominated fund.
Q&A: IPV Capital's Alex Banh
Semiconductors are a popular investment target in China on the back of US decoupling and a push for self-sufficiency. Alex Banh, a managing partner of sector specialist IPV Capital, shares his views
China regulatory crackdown threatens PE education deals
China has imposed severe restrictions on private tutoring that appear to undermine the commercial viability of companies in the space, potentially making private equity investment unviable.
CPE joins Series D for China biotech player TransThera
TransThera, a China-based drug developer, has raised $100 million in Series D funding led by CPE and China Structural Reform Fund.
China autonomous driving developer CalmCar raises $150m
CalmCar, a China-based provider of self-driving solutions, has closed a $150 million Series C round led by German auto parts supplier ZF Group. The company is targeting an IPO in 2022.
Sequoia leads $150m Series E for AIOps player Cloudwise
Cloudwise, a Beijing-based artificial intelligence operations (AIOps) provider, has raised $150 million in Series E funding led by Sequoia Capital China.
China DNA sequencing start-up gets $116m Series C
Chinese next-generation sequencing (NGS) player Geneplus Technology has raised a RMB750 million ($116 million) Series C round led by China Construction Bank’s venture unit CCB International.
Black Ant, GenBridge lead Series B for China coffee chain
M Stand - a China-based coffee shop chain with ambitions to become the Starbucks for China's younger generation - has raised RMB500 million ($77 million) in Series B funding led by Black Ant Capital and GenBridge Capital.
China petcare brand raises $31m
Chongxing, a Chinese petcare brand, has raised RMB200 million ($31 million) in a third tranche of Series B funding from Tencent Holdings, Hony Capital, HighLight Capital, Vertex Ventures China, and Meridian Capital.